Armata Pharmaceuticals Funding & Investors
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses to improve human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious disease of the microbiome. Armata Pharmaceuticals serves patients in the State of California.
armatapharma.comTotal Amount Raised: $197,000,000
Armata Pharmaceuticals Funding Rounds
Series D
$60,000,000
Series D Investors
Renaissance Holding CompanySeries Unknown
$30,000,000
Series Unknown Investors
Wyssta InvestmentsRenaissance Health ServiceCorvestaPost Ipo Debt
$30,000,000
Post Ipo Debt Investors
InnovivaPost Ipo Debt
$25,000,000
Post Ipo Debt Investors
InnovivaPost Ipo Equity
$45,000,000
Post Ipo Equity Investors
InnovivaPost Ipo Equity
$7,000,000
Post Ipo Equity Investors
InnovivaCystic Fibrosis Foundation
Funding info provided by Diffbot.